Heart disease is associated with increased sympathetic nerve activity and elevated levels of circulating catecholamines, resulting in chronic stimulation of the β-adrenergic receptors (β-AR) and consequent pathological cardiac remodeling. Experimentally, chronic administration of the β-AR agonist isoproterenol (ISO) has been most commonly used to model β-AR-induced cardiac remodeling. However, it remains unclear whether β-AR-mediated cardiac remodeling and dysfunction differs between sustained versus pulsatile (intermittent) exposure to a β-agonist. Here, we compare the effects of intermittent versus sustained administration of ISO on cardiac remodeling and function in mice. Animals were administered 5 mg (kg d) −1 ISO for 2 weeks either by daily subcutaneous injection, or continuous infusion via an implanted osmotic minipump. Cardiac function and remodeling were determined by echocardiography, micromanometry and histology. Moreover, Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR) were utilized to define the proteins and genes involved. Both sustained and intermittent administration of ISO resulted in a similar degree of cardiac hypertrophy (16% and 19%, respectively). However, mice receiving ISO by daily injection developed more severe ventricular systolic and diastolic dysfunction and myocardial fibrosis compared with mice receiving ISO via the osmotic minipump. The disparity in results between the delivery methods is suggested to be due, at least in part, to increased expression of fibrogenic factors, including connective tissue growth factor (CTGF) and NADPH oxidase (NOX4), in mice receiving intermittent application of ISO. In summary, compared with sustained exposure to a β-AR agonist, intermittent β-AR stimulation leads to more severe cardiac dysfunction and fibrosis. These findings not only further our understanding of β-AR function in the setting of cardiac pathophysiology, but also highlight that significant differences can result dependent upon the mode of experimental β-AR stimulation in inducing cardiomyopathy. 
Symptomatic heart failure and sudden cardiac death are major causes of morbidity and mortality worldwide. Increased cardiac sympathetic nerve activity is a predominant characteristic of patients suffering heart failure [1, 2] , and prolonged stimulation of the β-adrenergic neurohormonal axis has been shown to contribute to the progression of heart failure and mortality in both animal models and human patients [3, 4] . Excessive β-adrenergic receptor (β-AR) stimulation has been reported to induce cardiac myocyte apoptosis both in vivo and in vitro, as well as induce cardiac chamber remodeling associated with hypertrophy and/or fibrosis [5] [6] [7] . In the clinical setting, both sustained and intermittent patterns of β-AR stimulation have been described.
Hypertension is a prevalent cardiovascular disorder with a complex etiology. Currently, the pathophysiological mechanisms of essential hypertension are poorly understood; however, the disease is often associated with increased sympathetic nerve activity, elevated levels of circulating catecholamines and sustained β-AR stimulation [8, 9] . Transient β-AR stimulation following stress has also been reported to cause acute cardiomyopathy. Stress-induced cardiomyopathy is characterized by acute, but rapidly reversible, left ventricular systolic dysfunction in the absence of atherosclerotic coronary artery disease. Current reports suggest that stress-induced cardiomyopathy is triggered by intense psychological or physical stressors [10] . Moreover, as catecholamine levels are elevated during times of stress, it is proposed that the resultant cardiomyopathy is predominantly due to transient β-AR stimulation [11, 12] .
The use of isoproterenol (ISO), a powerful nonselective β-AR agonist, to model myocardial injury in the experimental setting was initiated by Rona et al. [13] and validated in subsequent studies [14, 15] . ISO treatment causes significant cardiac remodeling in rats, associated with severe myocardial hypertrophy and injury [16, 17] , as well as apoptosis of cardiomyocytes [6, 17] . Notably, ISO can be administered by different means, either by repeated subcutaneous injection (intermittent β-AR stimulation) or continuous subcutaneous infusion (sustained β-AR stimulation). Currently it remains unclear whether the extent of cardiac remodeling and dysfunction following β-AR stimulation differs between intermittent exposure to a β-agonist and sustained β-agonist administration.
The mitogen-activated protein (MAP) kinase superfamily, including extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK) and p38-kinase, is predominantly stimulated by growth factors, cellular stress or inflammatory cytokines. Of note, there is increasing evidence that MAP kinases play specific roles during the early development of cardiac hypertrophy [18] [19] [20] . Activation of the mammalian target of rapamycin (mTOR)/protein S6 kinase (p70S6k) signaling pathway by phenylephrine (PE) and angiotensin-II was found to stimulate protein synthesis and promote cardiac hypertrophy [21, 22] . Furthermore, application of ISO has been demonstrated to increase the phosphorylation of mTOR and p70S6k in vitro [23, 24] , implying the potential for ISO-induced cardiac hypertrophy to be mediated by the mTOR/p70S6k signaling pathway.
Cardiac hypertrophy and myocardial fibrosis are also associated with elevated generation of reactive oxygen species (ROS) [25, 26] and connective tissue growth factor (CTGF) is known to play an important role in the myocardial fibrosis process. There is evidence that ROS-related signaling pathways are involved in CTGF synthesis process which is important in AngII-induced cardiac fibrosis [27] . However, the role of CTGF in ISO-induced cardiac remodeling is not clearly understood.
The present study sought to determine whether different modes of β-AR stimulation impart differential actions on cardiac remodeling. The study further explored the potential mechanisms underlying these effects. (ii) ISO s.c. group: mice received daily subcutaneous injection of ISO (n=8); (iii) VC pump group: mice received continuous infusion of vehicle using an osmotic pump (n=8); (iv) ISO pump group: mice received continuous infusion of ISO using an osmotic pump (n=16). Echocardiography was used to evaluate heart rate, cardiac structure and function at specific time points following ISO administration. On day 14, echocardiography and hemodynamic analyses were performed for the final time before mice were sacrificed. As a side, osmotic pumps were removed from eight of the ISO-infused mice, and cardiac function was evaluated three days after pump removal.
Echocardiography and evaluation of left ventricular hemodynamics
Mice were anaesthetized using 1.5% isoflurane (Baxter Healthcare Corporation, New Providence, USA). Echocardiographic images were obtained using a Visualsonics highresolution Vevo 770 system (VisualSonics, Incorporated, Toronto, Canada). Two-dimensional parasternal long-axis views and short-axis views were obtained at the level of the papillary muscle. Diastolic left ventricular posterior wall thickness (LVPWd) and systolic left ventricular posterior wall thickness (LVPWs) were measured. Ejection fraction (EF) and fractional shortening (FS) were calculated from these parameters. All measurements were averaged from three consecutive cardiac cycles. To measure aortic and left ventricular (LV) pressure, a 1.4-F micromanometer conductance catheter (SPR-835; Millar Instruments, Incorporated, Houston, USA) was introduced through the right common carotid artery into the ascending aorta and then advanced into the left ventricle as previously described [28] .
Histology
Following sacrifice hearts were harvested and perfused in retrograde with cold phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde overnight, and embedded in paraffin. Serial sections (6 μm thick) were stained with hematoxylin and eosin (HE) for morphological analysis, or Sirius red for the detection of fibrosis. For morphometrical analysis, photographs of LV sections cut from the same location of each heart were observed under ×400 magnification. Cross-sectional images of cardiac myocytes (n=100 cells from each heart) were digitized using the Leica Q550 IW imaging workstation (Leica Microsystems Imaging Solutions Ltd., Cambridge, UK). Interstitial collagen type I and III were visualized using Sirius red stain under bright field and polarized light microscopy, and the cardiac collagen volume fraction was calculated as the ratio of the stained fibrotic area to total myocardial area.
Quantitative real-time PCR
Total RNA was isolated from heart tissue using Trizol Reagent (Invitrogen). Relative quantitation by real-time PCR was performed using SYBR Green to detect PCR products in real time with ABI PRISM 7700 Sequence Detection System (Applied Biosystems). The sequences of oligonucleotide primers were as follows: ANF, 5′-GCCCTGA-GTGAGCAGACTG-3′ (forward) and 5′-CGGAAGCTGT-TGCAGCCTA-3′ (reverse); Collagen-I, 5′-GTAACTTCG-TGCCTAGCAACA-3′ (forward) and 5′-CCTTTGTCAG-AATACTGAGCAGC-3′ (reverse); Collagen-III, 5′-CCTG-GCTCAAATGGCTCAC-3′ (forward) and 5′-CAGGACT-GCCGTTATTCCCG-3′ (reverse); CTGF, 5′-GGGCCTCT-TCTGCGATTTC-3′ (forward) and 5′-ATCCAGGCAAGT-GCATTGGTA-3′ (reverse); NOX4, 5′-ACTTTTCATTG-GGCGTCCTC-3′ (forward) and 5′-AGAACTGGGTCCA-CAGCAGA-3′ (reverse); GAPDH, 5′-TCCTGGTATGAC-AATGAATACGGC-3′ (forward) and 5′-TCTTGCTCAG-TGTCCTTGCTGG-3′ (reverse). GAPDH RNA was amplified as an internal control. The cell cycle was: 94°C for 2 min, followed by 40 cycles at 94°C for 15 s, 58°C for 15 s and 72°C for 30 s.
Western blot analysis
Protein expression was examined by Western blot analysis as previously described [29] . Proteins were electrophoresed and analyzed using anti-phospho-ERK1/2, anti-phospho-JNK1/2, anti-phospho-p38, anti-phospho-mTOR, anti-phospho-p70S6k, anti-JNK1/2, anti-mTOR, anti-p70S6k (Cell Signaling Technology Incorporated, Danvers, MA, USA), anti-ERK1/2, anti-p38, anti-CTGF, anti-eIF5 (Santa Cruz, CA, USA), and anti-NOX4 (Abcam Inc., Cambridge, MA).
Measurement of ROS
The amount of ROS expression in heart tissue was visualized by dihydroethidium (DHE) (Invitrogen Molecular Probes, Eugene, OR, USA) which gives red fluorescence when oxidized to ethidium in the presence of ROS. Serial sections (6 μm) of paraformaldehyde-fixed heart tissue were deparaffinized, rehydrated and incubated with 5 μmol L −1 DHE for 30 min at 37°C under 5% CO 2 in air. Sections were analyzed using a Leica digital camera mounted on a fluorescent microscope attached to a personal computer running Leica software.
Statistical analysis
All data are presented as the mean±SE. Inter-group comparisons were performed by a Student's paired two-tailed t-test or two-way ANOVA (Prism 4, GraphPad Software Incorporate, La Jolla, CA, USA). The Bonferroni test was used for post hoc analysis where significant variance occurred in the ANOVA. P<0.05 was considered statistically significant.
Results

Effects of ISO on heart rate
ISO caused a significant increase in the heart rate (HR) of mice. After peaking at 1 min (45% increase), the heart rate of mice receiving intermittent application of ISO decreased gradually to basal levels after 30 min. In contrast, animals receiving ISO by the minipump had a rapid although less pronounced increase in HR at 1 min (P<0.01 versus ISO injection), which was sustained and increased slightly over the experimental period, peaking at 26% above control (Figure 1 ).
ISO induces cardiac hypertrophy
Heart sections stained with HE revealed that administering ISO by injection or the pump significantly increased the mean cardiomyocyte cross-sectional area by 68% and 63% respectively, compared with their respective controls. No significant difference was found between ISO groups (Figures 2A and B) . Mice receiving ISO by injection or the pump both exhibited a significant increase in the ratio of heart weight to body weight (HW/BW) compared with ve- hicle (16% and 19% respectively); however the two ISO groups did not significantly differ ( Figure 2C ). ISO delivery also increased ANF mRNA expression with no significant difference between the two delivery methods ( Figure 2D ).
ISO-induced cardiac fibrosis
Observing the morphology, collagen deposition increased in response to ISO treatment by both modes of delivery. Mice receiving intermittent ISO injections exhibited significantly greater collagen deposition compared with the ISO pump group ( Figures 3A and B) . Quantitative analysis revealed cardiac interstitial fibrosis was markedly increased by 93% and 53% in ISO-injected and ISO-pump animals compared with their controls, respectively. Significantly, fibrosis was 54% greater in ISO-injected mice compared with ISO-pump mice (P<0.05, Figure 3C ). Consistent with this, quantitative RT-PCR analysis demonstrated that the relative mRNA content of myocardial collagen-I and collagen-III was significantly increased in ISO-treated mice, with ISO-injected mice displaying markedly higher levels of collagen-I and -III mRNA compared with the ISO pump group (Figures 3D  and E ).
Effect of ISO on cardiac function
Echocardiography revealed that FS and EF were significantly increased after 2 days of ISO treatment under both intermittent and continuous infusion protocols. Mice subjected to continuous infusion of ISO maintained FS and EF above control levels across the entire experimental period. In contrast, mice receiving injections of ISO displayed a decline in FS and EF following day 2, becoming consistent with basal levels on day 4, before further reducing to become significantly below control levels at the end of the experimental period ( Figures 4A, B and C) . Hemodynamic data were consistent with the echocardiograph findings where mice receiving ISO by injection exhibited a significant reduction in left ventricular force of contraction (+dP/dt) and relaxation (−dP/dt) ( Figures 4D and E) , to- 
Figure 2 ISO-induced cardiac hypertrophy in vivo. A, Representative micrographs of HE-stained sections of the left ventricle (LV). B, Mean myocyte cross-sectional area calculated from HE-stained sections of LVs (n=8). C, The ratio of heart weight (HW) to body weight (BW) (n=8). D, Expression of atrial natriuretic factor (ANF) mRNA normalized to that of GAPDH (n=6
Effects of ISO treatment on mTOR/p70S6k, MAPK and CTGF expression
Cardiac tissue from ISO-treated mice (both injected and continuously infused) exhibited a 2-fold increase in phospho-mTOR, and a 5-fold increase in the phosphorylation of its downstream molecule, p70S6k ( Figure 5A ). The level of phosphorylation of ERK1/2, JNK1/2, and p38 all increased to a similar extent under both ISO-delivery methods after 14 days of administration ( Figure 5B ). CTGF mRNA and protein expression were also significantly elevated in both ISO-treated groups compared with vehicle, with intermittent delivery of ISO causing a greater increase in CTGF mRNA and protein than continuous infusion ( Figures 5C and D) .
Effect of ISO on ROS production and NADPH oxidase
LV sections stained with DHE revealed ISO-treated mice to have a marked increase in the amount of oxidation ( Figure   6A ). Western blot and qRT-PCR analysis both found NOX4 (an isoform of NADPH oxidase) expression to be significantly increased following ISO treatment in both delivery groups; however, this was to a greater extent in the injected ISO group (Figures 6B and C) .
Discussion
A previous study demonstrated that the nature of the stress on the heart, rather than its duration, is the primary determinant of the resulting pathological phenotype [30] . The current study sought to address a similar hypothesis, inves- tigating whether exposure to different patterns of the same stress could result in different pathological phenotypes in the heart. Here, we demonstrated that different patterns of β-AR stimulation resulted in similar levels of cardiac hypertrophy; however, significantly differed in their degree of cardiac fibrosis and cardiac dysfunction. Intermittent application of ISO was found to cause the greatest detrimental effects on the heart, including greater ROS production and expression of NOX4 compared with mice continuously infused. Taken together, these results indicate that intermittent β-AR activation is more prone to induce maladaptive cardiac remodeling and dysfunction than sustained β-AR stimulation. ISO, the potent, nonselective β-AR agonist used in the current study is well reported to have positive inotropic actions and dose-dependently increase heart rate [31, 32] . In our study, ISO-induced changes in heart rate were found to be dependent upon the two methods of drug delivery. Animals receiving ISO by subcutaneous injection produced the greatest increase in heart rate (45%) at 1 min, before reducing to become equal with basal levels after 30 min. In contrast, the heart rate of animals receiving a continuous infusion of ISO via a minipump was elevated by 26% within the first minute of infusion and remained significantly elevated throughout the experimental period. The different responses in heart rate dependent upon the method of ISO delivery reflect that daily injections and continuous infusion of ISO provided a good model of intermittent and sustained β-AR stimulation, respectively. It is also apparent that animals receiving a bolus injection of ISO induced greater β-AR stimulation compared with continuous ISO infusion, despite receiving the same dose per day.
Studies observing the effects of ISO-induced cardiac remodeling to date have applied a wide range of doses and used various methods of administration. For example, Kitagawa Y et al. reported ISO to induce cardiac hypertrophy and fibrosis following continuous infusion of ISO at both 1.2 mg (kg d) −1 and 2.4 mg (kg d) −1 by an osmotic pump [16] . Similarly, studies administering ISO by subcutaneous injection reported ISO to induce cardiac hypertrophy and fibrosis in a dose-dependent manner [17] . Consistent with these reports, the current study directly contrasted the two methods of ISO delivery, revealing the degree of cardiac hypertrophy to be equivalent following both patterns of β-AR stimulation. Similarly, Hohimer A R et al. reported that one subcutaneous injection of 20 μg g −1 ISO per day for 5 consecutive days caused increases in ventricular weight/body weight equivalent to 5 daily infusions at 20 μg (g d) −1 [33] .
Increased collagen synthesis is considered to be an indicator of interstitial fibrosis. In the present study, we estimated collagen synthesis by both Sirius red staining and measuring the mRNA content of myocardial collagen-I and collagen-III. These analyses revealed that intermittent β-AR stimulation led to more severe interstitial fibrosis compared with sustained β-AR stimulation. Cardiac hemodynamic function is heavily influenced by cardiac fibrosis. Observing cardiac function in the current study, it was evident that 2 weeks of intermittent β-AR stimulation induced significant cardiac dysfunction. In contrast, continuous infusion of ISO increased cardiac systolic function, suggested to be due to the continuous positive inotropic effect of ISO. This result is consistent with a prior report infusing ISO by the osmotic pump to mice for 7 days [34] . Following removal of the ISO pump, systolic function was preserved, suggesting compen-satory pathological cardiac remodeling occurred. Together, these findings suggest that intermittent β-AR activation is more prone to induce maladaptive cardiac remodeling and dysfunction than sustained β-AR stimulation.
To elucidate the potential signaling pathways underlying the distinct actions of intermittent and sustained β-AR stimulation on cardiac remodeling, we examined signaling pathways known to be associated with cardiac remodeling. In our hands, both intermittent and sustained application of ISO caused equivalent activation of mTOR/p70S6k and MAPKs (including ERK, p38 and JNK). Recently, Xu Q et al. demonstrated that β 2 -adrenoceptor stimulation provoked NADPH oxidase-derived ROS production in the heart, which contributed to cardiac inflammation, remodeling and heart failure [35] . Furthermore, there is increasing evidence that ROS-related signaling pathways can modulate CTGF synthesis, a key mediator of AngII-induced cardiac fibrosis [27] . The current study found that ROS production, as well as NOX4 and CTGF expression all increased with ISO treatment. Interestingly, intermittent ISO delivery caused greater ROS production, as well as increased NOX4 and CTGF expression compared with continuous ISO infusion. These results strongly suggest that a ROS-related pathway contributes to developing cardiac fibrosis and cardiac dysfunction, with intermittent application of ISO exacerbating the pathological effects. The intriguing disparate results following intermittent and sustained β-AR stimulation on ROS-related signaling proteins require further investigation, including determining the level of MDA and NADPH oxidase activity.
In conclusion, the current study demonstrates that both intermittent and sustained stimulation of β-AR cause cardiac hypertrophy to a similar extent. However, intermittent β-AR stimulation leads to more severe cardiac fibrosis and cardiac dysfunction compared with sustained β-AR stimulation. Our findings significantly further our understanding of β-AR stimulation in relation to cardiac pathophysiology, highlighting the importance of the mode of drug delivery at both the clinical and experimental setting.
